Multicenter, Double-blind, Randomized Controlled Trial of Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)

Condition:   SARS-CoV-2 Infection Interventions:   Drug: Tocilizumab (TCZ);   Drug: Placebo Sponsors:   University Hospital Inselspital, Berne;   Roche Pharma AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials